Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with ...
Whether revascularization by percutaneous coronary intervention (PCI) can improve event-free survival and left ventricular function in patients with severe ischemic left ventricular systolic ...
Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations The following represents disclosure information provided by ...
HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.
Demographic, systemic sclerosis (SSc)-specific, and cardiac factors raised the risk for left ventricular systolic dysfunction (LVSD) in a study of patients with SSc. Researchers used the Johns Hopkins ...
In a U.S. ED observation TIA cohort, transthoracic echocardiography identified high risk cardioembolic features in nearly 1 in 5, most often patent foramen ovale and reduced LVEF.
Focused cardiac ultrasonography is a practical, transthoracic, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results